ABSTRACT
Aim: Meconium-stained amniotic fluid was related to fetal discomfort and, if untreated, may have deadly consequences. To identify risk factors and potential therapeutic approaches, researchers examined data from hospital births.  
Methods: Between June 2020 and May 2021 in Holy Family Hospital, Rawalpindi, every live birth that took place at the facility was examined for potential confounders, health results, and therapy options for meconium aspiration disorder.
Results: 173 out of 2450 live births, or 68 per 1100 live births, contained amniotic fluid that was contaminated with meconium. 23 (7.8%) of 165 patients with MSAF had MAS. Six (24.82%) of the 20 MAS patients required CPAP assistance, and five (18.05%) required mechanical ventilation. In the current investigation, there was just one fatality.
Conclusion: As per our research, several health conditions for meconium aspiration disorder include elevated maternal age, pre-term in addition post term pregnancy, oligohydramnios, small for gestational age, preterm membrane rupture, and APGAR score 8.
Keywords: Meconium-Stained Amniotic Fluid, Fetal Discomfort, Therapeutic Approaches.